These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pulmonary embolism: what happens to the emboligenic focus?]. Serradimigni A; Philip F; Elias A; Lecorff G Haemostasis; 1986; 16 Suppl 4():69-78. PubMed ID: 3770559 [No Abstract] [Full Text] [Related]
25. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study. Bell WR Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689 [TBL] [Abstract][Full Text] [Related]
32. Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Sharma GV; Folland ED; McIntyre KM; Sasahara AA Vasc Med; 2000; 5(2):91-5. PubMed ID: 10943585 [TBL] [Abstract][Full Text] [Related]
33. [Subacute or chronic thromboembolism of the pulmonary artery. The role of fibrinolytic treatment (apropos of 9 cases)]. Benaim R; Calvo G; Fischler M; Chiche P Ann Med Interne (Paris); 1976 Oct; 127(10):767-70. PubMed ID: 795338 [No Abstract] [Full Text] [Related]
34. Current status of thrombolytic therapy. Cudkowicz L; Sherry S Heart Lung; 1978; 7(1):97-100. PubMed ID: 244489 [No Abstract] [Full Text] [Related]
35. Thrombolytic therapy of pulmonary embolism: a meta-analysis. Thabut G; Thabut D; Myers RP; Bernard-Chabert B; Marrash-Chahla R; Mal H; Fournier M J Am Coll Cardiol; 2002 Nov; 40(9):1660-7. PubMed ID: 12427420 [TBL] [Abstract][Full Text] [Related]
38. Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference. Ann Intern Med; 1980 Jul; 93(1):141-4. PubMed ID: 7396293 [No Abstract] [Full Text] [Related]